BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24608100)

  • 1. Time-Resolved Fluorescence Resonance Energy Transfer Assay for Discovery of Small-Molecule Inhibitors of Methyl-CpG Binding Domain Protein 2.
    Wyhs N; Walker D; Giovinazzo H; Yegnasubramanian S; Nelson WG
    J Biomol Screen; 2014 Aug; 19(7):1060-9. PubMed ID: 24608100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a High-Throughput Assay for Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1 Based on Time-Resolved Fluorescence Energy Transfer.
    Kim TG; Lee JH; Lee MY; Kim KU; Lee JH; Park CH; Lee BH; Oh KS
    Biol Pharm Bull; 2017; 40(9):1454-1462. PubMed ID: 28867728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).
    Schröter T; Minond D; Weiser A; Dao C; Habel J; Spicer T; Chase P; Baillargeon P; Scampavia L; Schürer S; Chung C; Mader C; Southern M; Tsinoremas N; LoGrasso P; Hodder P
    J Biomol Screen; 2008 Jan; 13(1):17-28. PubMed ID: 18227223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A time-resolved fluorescence resonance energy transfer assay for high-throughput screening of 14-3-3 protein-protein interaction inhibitors.
    Du Y; Fu RW; Lou B; Zhao J; Qui M; Khuri FR; Fu H
    Assay Drug Dev Technol; 2013 Jul; 11(6):367-81. PubMed ID: 23906346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay for the Inhibition of Keap1-Nrf2 Protein-Protein Interaction.
    Lee S; Abed DA; Beamer LJ; Hu L
    SLAS Discov; 2021 Jan; 26(1):100-112. PubMed ID: 32564647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a FOXM1-DBD Binding Assay for High-Throughput Screening Using TR-FRET Assay.
    Lee MY; Haam CE; Mun J; Lim G; Lee BH; Oh KS
    Biol Pharm Bull; 2021; 44(10):1484-1491. PubMed ID: 34602556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Dual Readout Assay Based on Fluorescence Polarization and Time-Resolved Fluorescence Resonance Energy Transfer to Screen for RSK1 Inhibitors.
    Jeong EM; Lee MY; Lee JH; Lee BH; Oh KS
    Biol Pharm Bull; 2016; 39(4):547-55. PubMed ID: 27040627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dual-readout F2 assay that combines fluorescence resonance energy transfer and fluorescence polarization for monitoring bimolecular interactions.
    Du Y; Nikolovska-Coleska Z; Qui M; Li L; Lewis I; Dingledine R; Stuckey JA; Krajewski K; Roller PP; Wang S; Fu H
    Assay Drug Dev Technol; 2011 Aug; 9(4):382-93. PubMed ID: 21395401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence polarization and time-resolved fluorescence resonance energy transfer techniques for PI3K assays.
    Horiuchi KY; Ma H
    Methods Mol Biol; 2009; 572():161-76. PubMed ID: 20694691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A General TR-FRET Assay Platform for High-Throughput Screening and Characterizing Inhibitors of Methyl-Lysine Reader Proteins.
    Rectenwald JM; Hardy PB; Norris-Drouin JL; Cholensky SH; James LI; Frye SV; Pearce KH
    SLAS Discov; 2019 Jul; 24(6):693-700. PubMed ID: 31017815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multiplexed time-resolved fluorescence resonance energy transfer ultrahigh-throughput screening assay for targeting the SMAD4-SMAD3-DNA complex.
    Ouyang W; Li Q; Niu Q; Qui M; Fu H; Du Y; Mo X
    J Mol Cell Biol; 2024 Apr; 15(11):. PubMed ID: 37968137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A time-resolved fluorescence resonance energy transfer assay suitable for high-throughput screening for inhibitors of immunoglobulin E-receptor interactions.
    Kim B; Tarchevskaya SS; Eggel A; Vogel M; Jardetzky TS
    Anal Biochem; 2012 Dec; 431(2):84-9. PubMed ID: 22995065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing False Positives through the Application of Fluorescence Lifetime Technology: A Comparative Study Using TYK2 Kinase as a Model System.
    Greenhough LA; Clarke G; Phillipou AN; Mazani F; Karamshi B; Rowe S; Rowland P; Messenger C; Haslam CP; Bingham RP; Craggs PD
    SLAS Discov; 2021 Jun; 26(5):663-675. PubMed ID: 33783261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
    Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP
    J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform.
    Lebakken CS; Riddle SM; Singh U; Frazee WJ; Eliason HC; Gao Y; Reichling LJ; Marks BD; Vogel KW
    J Biomol Screen; 2009 Sep; 14(8):924-35. PubMed ID: 19564447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG and methylation-dependent DNA binding and dynamics of the methylcytosine binding domain 2 protein at the single-molecule level.
    Pan H; Bilinovich SM; Kaur P; Riehn R; Wang H; Williams DC
    Nucleic Acids Res; 2017 Sep; 45(15):9164-9177. PubMed ID: 28637186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput fluorescence polarization assay for chemical library screening against anti-apoptotic Bcl-2 family member Bfl-1.
    Zhai D; Godoi P; Sergienko E; Dahl R; Chan X; Brown B; Rascon J; Hurder A; Su Y; Chung TD; Jin C; Diaz P; Reed JC
    J Biomol Screen; 2012 Mar; 17(3):350-60. PubMed ID: 22156224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction.
    Xiong J; Pecchi VG; Qui M; Ivanov AA; Mo X; Niu Q; Chen X; Fu H; Du Y
    Assay Drug Dev Technol; 2018; 16(2):96-106. PubMed ID: 29634317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Throughput Spectral and Lifetime-Based FRET Screening in Living Cells to Identify Small-Molecule Effectors of SERCA.
    Schaaf TM; Peterson KC; Grant BD; Bawaskar P; Yuen S; Li J; Muretta JM; Gillispie GD; Thomas DD
    SLAS Discov; 2017 Mar; 22(3):262-273. PubMed ID: 27899691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TR-FRET-based high-throughput screening assay for identification of UBC13 inhibitors.
    Madiraju C; Welsh K; Cuddy MP; Godoi PH; Pass I; Ngo T; Vasile S; Sergienko EA; Diaz P; Matsuzawa S; Reed JC
    J Biomol Screen; 2012 Feb; 17(2):163-76. PubMed ID: 22034497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.